Who Can Benefit from SWT?

Shockwave therapy is typically recommended for:

• Individuals with chronic tendinopathies (>6 months)

  
  
  
  
  
  

• Patients who haven’t responded to conventional therapy

  
  
  
  
  
  

• Those seeking a non-surgical treatment option

  
  
  
  
  
  

Contraindications include: pregnancy, blood clotting disorders, infections at the treatment site, and certain cardiovascular conditions.

Final Thoughts

Shockwave therapy has evolved from a niche physiotherapy modality to a mainstream, evidence-based treatment for many musculoskeletal injuries. With growing statistical support and minimal side effects, it's becoming a preferred option for clinicians and patients alike.

If you're struggling with chronic musculoskeletal pain and conventional treatments haven’t worked, it may be time to explore shockwave therapy — backed not just by hope, but by hard data.

References

1. Speed, C. A. (2004). Extracorporeal shock-wave therapy in the management of chronic soft-tissue conditions. J Bone Joint Surg Br, 86(2), 165–171.

   
   
   
   
   
   

2. Gerdesmeyer, L., et al. (2003). Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic recalcitrant plantar fasciitis. Am J Sports Med, 31(11), 268–275.

   
   
   
   
   
   

3. Kearney, R. S., et al. (2015). Shockwave therapy for Achilles tendinopathy. Br J Sports Med, 49(23), 1546–1550.

   
   
   
   
   
   

4. Lou, J., et al. (2018). Efficacy of extracorporeal shockwave therapy for plantar fasciitis: a meta-analysis. J Orthop Surg Res, 13(1), 196.